Discovery
Rejuvenation Technologies backed with grant to move TERT mRNA into clinic for alcoholic hepatitis
Rejuvenation Technologies, Inc., a Mountain View, California-based biotechnology company, has received a USD 2.06 million NIAAA SBIR Commercialization...
Chicago Uni engineers bacteria to deliver immunotherapy directly to pancreatic tumors
The University of Chicago has received a USD 1.75 million National Cancer Institute R01 award to develop genetically engineered Bifidobacterium as a...
Henry Ford Health secures NIH funding for inhaled IPF therapy based on vonoprazan
Henry Ford Health + Michigan State University Health Sciences has received a USD 1.56 million NIH R01 grant from the National Heart, Lung, and Blood...
VCU advances dual EGFR/HER2 degradation strategy to overcome drug resistance in lung cancer
Virginia Commonwealth University has received a USD 1.74 million National Cancer Institute R01 award to advance preclinical evaluation of PEPDG278D, a...
Broad Institute advances gene editing to permanently lower prion protein and halt neurodegeneration
The Broad Institute has received a USD 11.3 million NIH U19 renewal to advance gene editing approaches aimed at permanently lowering prion protein (PrP)...
Memorial Sloan Kettering builds diverse stem cell knockout catalog to study autism and type 2 diabetes genes
Memorial Sloan-Kettering Cancer Center has received a USD 1.78 million NIH UM1 renewal to continue building a large-scale catalog of human gene knockout...
UCSF engineers ALPPL2-targeted bispecific TCE aiming for solid cancers
University of California, San Francisco has received a USD 1.64 million National Cancer Institute R01 award to develop a bispecific T cell engager targeting...
Feinstein Institutes secures NIH funding for inflammation and Alzheimer's disease research
Feinstein Institutes for Medical Research has received USD 4.9 million in NIH grants across two multi-year awards targeting acute inflammation and...
Washington Uni secures USD 16.5m to expand DIAN-TU anti-tau Alzheimer's platform
The Washington University neurology department in St. Louis has received a USD 16.5 million NIA R01 renewal to continue the Dominantly Inherited Alzheimer...
Moffitt wins USD 1.66 million NCI grant to target MYC-driven inflammation in myelofibrosis
Moffitt Cancer Center has received a USD 1.66 million National Cancer Institute R01 renewal to investigate a MYC-driven inflammatory pathway as a potential...
New York Genome Center aims to lower barriers to spatial multi-omics with NIH funding
New York Genome Center (NYGC) has received a USD 2.68 million NIH R01 grant from the National Human Genome Research Institute to develop a cost-accessible...
Washington Uni explores whether sleep aid suvorexant can slow Alzheimer's pathology
Washington University in St. Louis has received a USD 1.47 million National Institute on Aging R01 renewal to evaluate whether chronic treatment with the...
MSK backed by NCI to explore lethal hyperactivation of WNT, MAPK, and PI3K in colorectal cancer
Memorial Sloan-Kettering Cancer Center has received a USD 1.71 million NCI OT2 award to pursue a counterintuitive approach to colorectal cancer treatment:...
CraniUS wins NIH support to advance NeuroPASS brain drug delivery platform toward glioblastoma trial
Baltimore-based CraniUS Therapeutics has received an initial USD 1.1 million award through the NIH Blueprint MedTech Optimizer Program, with the potential...
Siren Bio advances AAV immune-gene therapy into clinical trials for recurrent glioblastoma
San Francisco-based Siren Biotechnology has received a USD 8 million CLIN2 grant from the California Institute for Regenerative Medicine (CIRM) to advance...
The AllSci Brief
Systematic R&D and deal news. Daily.